by Grant Title

Title, Institution

Award Cycle, Investigator

Award [sort]

(-) Lobeline: total synthesis and derivitization	2002 (Cycle XI)	$60,000
California Institute of Techno	Jeffrey Bagdanoff B.S.	11DT-0193

11th National Conference on Nicotine Dependence	1998 (Cycle VII)	$12,000
American Society of Addiction<	Lori Karan M.D.	7ST-0198

2nd East West Conference on Tobacco and Alcohol	2005 (Cycle XIV)	$15,000
University of Southern Califor	Andy Johnson	14ST-0190

2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth	1995 (Cycle IV)	$149,221
The Burnham Institute of Medic	Hudson Freeze Ph.D.	4IT-0225

50000 Fold Signal Enhancement for Imaging Vulnerable Plaque	2007 (Cycle XVI)	$213,845
Huntington Medical Research In	Pratip Bhattacharya PhD	16KT-0044

A dynamic model of smoking and healthcare expenditures in CA	2000 (Cycle IX)	$595,843
University of California, San<	Wendy Max Ph.D.	9RT-0157

A Genetic Marker of Lung Cancer Risk Among Blacks & Whites	1992 (Cycle I)	$1,036,615
University of Southern Califor	Stephanie London M.D., Ph.D.	1RT-0140

A Hypothalamic Mechanism of Nicotine Reward and Addiction	1993 (Cycle II)	$61,640
University of California, San<	Dennis Rasmussen Ph.D.	2IT-0040

A longitudinal study of smoking transitions in youth	1999 (Cycle VIII)	$577,574
University of California, San<	Elizabeth Gilpin M.S.	8RT-0086

A Metabolic Mechanism of Action of Antiischemic Agents	1993 (Cycle II)	$225,000
University of California, Los<	Freny Mody M.D.	2KT-0049

A Methodological Multi-Ethnic Study of Smoking Initiation	1995 (Cycle IV)	$260,978
University of California, Los<	Celia Kaplan Dr.P.H.	4RT-0257

A mindfulness-based approach to relapse prevention	2005 (Cycle XIV)	$134,325
California Pacific Medical Cen	Cassandra Vieten Ph.D.	14IT-0178

A model system for smoking-related damage to proteins	1999 (Cycle VIII)	$75,375
J. David Gladstone Institutes<	Johan Bjorkegren M.D., Ph.D.	8FT-0022

A New Approach for Studying the Mechanism of Squamous Metapl	1995 (Cycle IV)	$75,000
University of California, Los<	Sanford Barsky M.D.	4IT-0328

A new molecular approach for predicting lung cancer	2000 (Cycle IX)	$75,000
University of California, Irvi	Ram Kumar Sindhu Ph.D.	9IT-0121

A novel approach to prevent in utero nicotine lung injury	2005 (Cycle XIV)	$553,441
LA Biomedical Research Institu	Virender Rehan M.D.	14RT-0073

A novel FMRI smoking craving and reward paradigm	2003 (Cycle XII)	$96,949
University of California, Los<	John Monterosso Ph.D.	12IT-0198

A novel lung tumor suppressor	1997 (Cycle VI)	$144,038
The Burnham Institute of Medic	Steven Frisch Ph.D.	6IT-0128

A novel therapeutic target for stroke	1997 (Cycle VI)	$71,810
The Burnham Institute of Medic	Li-Tao Zhong M.D., Ph.D.	6FT-0157

A novel total synthesis of brazilin and brazilide A	2005 (Cycle XIV)	$59,500
University of California, Sant	Yaodong Huang M.S.	14DT-0130

A novel, 3-dimensional approach to non-invasive diagnostics	2005 (Cycle XIV)	$99,000
University of California, Irvi	Petra Wilder-Smith D.D.S., Ph.D.	14IT-0097

A retroviral link to human tobacco-related lung cancer?	1999 (Cycle VIII)	$72,500
University of California, Los<	Sanford Barsky M.D.	8IT-0046

A Smokeless Tobacco Cessation Intervention:College Athletes	1992 (Cycle I)	$648,997
University of California, San<	Margaret Walsh MS, EdD	1RT-0574

A Smokeless Tobacco Cessation Program: High School Athletes	1995 (Cycle IV)	$533,923
University of California, San<	Margaret Walsh MS, EdD	4RT-0068

A Smoking Prevention Model for Low Income Minority Youth	1992 (Cycle I)	$323,095
Charles R. Drew University of<	Donna Davis Ph.D.	1KT-0035

A stage-based scheduled smoking intervention for Chinese	2005 (Cycle XIV)	$554,500
University of California, San<	Janice Tsoh Ph.D.	14RT-0160H

A study of Bax, a gene involved in killing tumor cells	1998 (Cycle VII)	$74,980
The Burnham Institute of Medic	Shahrzad Nouraini Ph.D.	7FT-0100

A web-based support community as a tool for ST cessation	2003 (Cycle XII)	$100,000
University of California, San<	Margaret Walsh MS, EdD	12IT-0169

Acculturation & cigarette smoking among Asian-Americans	1997 (Cycle VI)	$244,715
University of Southern Califor	Xinguang Chen Ph.D.	6KT-0191

Acculturation, media, peers, parents and adolescent smoking	1998 (Cycle VII)	$132,339
University of Southern Califor	Jennifer Unger Ph.D.	7PT-7004H

Acetylcholine Receptors in the Developing Nervous System	1994 (Cycle III)	$116,263
University of California, San<	Kent Keyser Ph.D.	3RT-0157

Activated Protein C in Smokers Thrombosis	1993 (Cycle II)	$347,737
Scripps Research Institute	Andras Gruber M.D.	2RT-0342

Activation and detoxification of lung cancer carcinogens	2006 (Cycle XV)	$420,000
University of California, San<	Robert Tukey Ph.D.	15RT-0251

Activation of Bnip3 in tobacco-induced heart disease	2005 (Cycle XIV)	$134,074
Scripps Research Institute	Asa Gustafsson Ph.D.	14KT-0109

Activation of Bnip3 in tobacco-induced heart disease	2005 (Cycle XIV)	$156,986
San Diego State University Res	Asa Gustafsson Ph.D.	14KT-0109A

Activation of NF-kB by cigarette smoke	1999 (Cycle VIII)	$224,217
University of California, Davi	Richart Harper M.D.	8KT-0092

Acute & Chronic Effects of Tobacco & Non-tobacco Smoking	1992 (Cycle I)	$27,491
University of California, Los<	Enrique Gil M.D.	1FT-0042

Acute & Chronic Nicotine Treatment on Gastric Ulceration	1992 (Cycle I)	$70,000
University of California, Los<	Kazuo Endoh M.D.	1FT-0037

Ad and Movie Imagery and Teen's Perceptions About Smokers	1995 (Cycle IV)	$183,689
University of California, Irvi	Cornelia Pechmann Ph.D.	4RT-0082

Addressing Substance Abusers Who Also Smoke	1994 (Cycle III)	$270,931
Northern California Institute<	Karen Sees D.O.	3KT-0121

Adenosine Airway Reactivity & Receptors in Smokers	1992 (Cycle I)	$93,500
University of California, Davi	Jesse Joad M.D.	1RT-0155

Adolescent Susceptibility to Tobacco: A Panel Analysis	1997 (Cycle VI)	$465,917
University of California, Irvi	Larry Jamner Ph.D.	6PT-3003H

Adolescent susceptibility to tobacco: a panel analysis	2001 (Cycle X)	$495,433
University of California, Irvi	Larry Jamner Ph.D.	10RT-0255

Advances in Lung Cancer Detection with Digital Techniques	1993 (Cycle II)	$276,730
University of California, Los<	Denise Aberle M.D.	2RT-0081

Affect Regulation in the Prevention of Smoking Relapse	1993 (Cycle II)	$70,601
Northern California Institute<	Timothy Carmody Ph.D.	2IT-0014

African American church role in tobacco norm change	2005 (Cycle XIV)	$126,317
Health Education Council	Ayanna Kiburi M.P.H.	14IT-0188

African Americans and Mentholated Cigarettes	1999 (Cycle VIII)	$417,968
Charles R. Drew University of<	Bruce Allen Dr. P.H.	8RT-0091H

African Americans: NRT or Alternative Medicine for Cessation	2006 (Cycle XV)	$270,000
University of California, San<	Valerie Yerger ND, MA	15KT-0038

Aggression and Nicotine	1997 (Cycle VI)	$229,826
University of California, Irvi	Larry Jamner Ph.D.	6RT-0154

Airway transcriptome changes in smokers	2004 (Cycle XIII)	$99,500
University of California, San<	John Fahy M.D.	13IT-0097

ALAC 2003 Annual Conference	2003 (Cycle XII)	$5,000
American Lung Association of C	Steve O'Kane	12ST-0264

ALAC Annual Conference	2005 (Cycle XIV)	$2,500
American Lung Association of C	Lynn Devine	14ST-0192

ALAC Annual Conference	2006 (Cycle XV)	$5,000
American Lung Association of C	Kerlyn Chatelain-Graham	15ST-0258

ALAC Annual Conference	2007 (Cycle XVI)	$5,000
American Lung Association of C	Laura Keegan	16ST-0217

ALAC Conference	2004 (Cycle XIII)	$5,000
American Lung Association of C	Laura Keegan	13ST-0175

Allocation of Health Care to Smokers: Practice and Ethics	1998 (Cycle VII)	$113,598
Stanford University	Thomas Raffin M.D.	7IT-0129

*Alpha4 Nicotinic Receptor in Dopaminergic System**	2007 (Cycle XVI)	$75,500
California Institute of Techno	Cheng Xiao Ph.D.	16FT-0066

Alterations in gene expression after tobacco smoke exposure	1997 (Cycle VI)	$216,612
University of California, Davi	Ken Yoneda M.D.	6KT-0016

Alternative sources of ETS exposure in infants	1998 (Cycle VII)	$109,687
San Diego State University Res	Georg Matt Ph.D.	7IT-0087

Amnesty Smoking Prevention Project	1992 (Cycle I)	$686,087
University of Southern Califor	Richard Scribner M.D.	1RT-0545

An athletic trainer mediated spit tobacco cessation program	1998 (Cycle VII)	$497,539
University of California, San<	Margaret Walsh MS, EdD	7RT-0058

An economic analysis of factors influencing teen smoking	1998 (Cycle VII)	$221,497
University of California, San<	Sherry Emery MBA, Ph.D.	7KT-0193

An Endogenous Lectin in Airway Epithelium & Lung Cancer	1992 (Cycle I)	$463,703
University of California, San<	Hakon Leffler M.D., Ph.D.	1RT-0279

An Idea for a Cohort Study of Tobacco-Related Cancers	1993 (Cycle II)	$73,428
University of California, Los<	Matthew Longnecker	2IT-0008

An RNA biomarker for tobacco smoke toxicity	1999 (Cycle VIII)	$51,751
University of California, Davi	Richard Kimura	8DT-0174

Anabolic therapies for muscle dysfunction in women with COPD	2001 (Cycle X)	$632,153
LA Biomedical Research Institu	Richard Casaburi M.D., Ph.D.	10RT-0046

Analysis of a candidate lung tumor suppressor gene at 3p21.3	2000 (Cycle IX)	$111,410
Beckman Research Institute of<	Gerd Pfeifer Ph.D.	9RT-0175

Analysis of a lung tumor supressor gene at 3p21.3	2001 (Cycle X)	$249,438
Beckman Research Institute of<	Gerd Pfeifer Ph.D.	10RT-0016

Analysis of a nicotine-related receptor binding site	1997 (Cycle VI)	$68,718
University of California, San<	Laura England Ph.D.	6FT-0103

Analysis of California adolescent tobacco data	2001 (Cycle X)	$475,742
University of California, Los<	William McCarthy Ph.D.	10RT-0333

Analysis of RAS Mutations in the Canine Smoking Model	1992 (Cycle I)	$70,000
University of California, Davi	Susan Kraegel D.V.M.	1FT-0073

Analysis of Retinoid Mediated Anti-cancer Activities	1993 (Cycle II)	$757,415
The Burnham Institute of Medic	Magnus Pfahl Ph.D.	2RT-0109

Analysis of the Effect of Natl Policies on Smoking Behavior	1992 (Cycle I)	$579,489
University of California, San<	John Pierce Ph.D.	1RT-0245

Analysis of tobacco industry documents on scientific researc	2000 (Cycle IX)	$442,646
University of California, San<	Lisa Bero Ph.D.	9RT-0193

Angiotensin II and Restenosis after Coronary Angioplasty	1993 (Cycle II)	$228,018
University of California, Davi	Jerry Powell M.D.	2RT-0326

Angiotensin II Regulation of the Cardiac Fibroblast	1994 (Cycle III)	$219,533
University of California, San<	Francisco Villarreal M.D., Ph.D.	3KT-0205

Animal Models of Human Risk from Environmental Tobacco Smoke	1994 (Cycle III)	$135,482
University of California, Davi	Philip Kass D.V.M., Ph.D.	3KT-0071

Antiatherogenic helical segments of apo A-I	2004 (Cycle XIII)	$141,230
Lawrence Berkeley National Lab	John Bielicki Ph.D.	13IT-0025

Antimicrobial Proteins of Human Alveolar Macrophages	1993 (Cycle II)	$71,549
University of California, Los<	Robert Lehrer M.D.	2IT-0017

Antioxidants, cigarette smoking and atherosclerosis	1998 (Cycle VII)	$730,640
University of Southern Califor	James Dwyer Ph.D.	7RT-0034

Antismoking slides in movie Theaters: A Naturalistic Eval	2000 (Cycle IX)	$10,000
University of California, Irvi	Cornelia Pechmann Ph.D.	9ST-0244

Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing	1997 (Cycle VI)	$452,574
University of California, Los<	Barbara Berman Ph.D.	6RT-0047

ApoE isoforms, fatty acid metabolism and atherosclerosis	2001 (Cycle X)	$691,616
J. David Gladstone Institutes<	Robert Pitas Ph.D.	10RT-0313

Apolipoprotein E: remnant metabolism and atherogenesis	1999 (Cycle VIII)	$793,474
J. David Gladstone Institutes<	Yadong Huang M.D., Ph.D.	8RT-0130

Apolipoprotein(a) and Cardiovascular Disease	1993 (Cycle II)	$590,733
Stanford University	Richard Lawn Ph.D.	2RT-0339

Ascertainment of environmental tobacco exposure in pregnancy	1999 (Cycle VIII)	$1,843,747
Sequoia Foundation	Martin Kharrazi Ph.D.	8RT-0115

Asian American and Pacific Islander (AAPI) Sci. Conf./Wkshp.	2007 (Cycle XVI)	$5,000
University of California, Los<	Yih-Ing Hser Ph.D.	16ST-0214

Assessing nicotine relapse in a mouse model	2001 (Cycle X)	$52,817
SRI International	Taline Khroyan Ph.D.	10KT-0007

Assessing Organizational Influence on Chinese Smoking	1993 (Cycle II)	$75,150
University of California, Los<	Virginia Li Ph.D., M.P.H.	2IT-0070

Assessing Tobacco Refusal Skills in Latino Youth	1992 (Cycle I)	$584,719
San Diego State University Res	James Sallis Ph.D.	1RT-0588

Assessment of Teen Tobacco Use by Primary Care Physicians	1993 (Cycle II)	$70,000
University of California, San<	Merula Franzgrote M.D.	2FT-0063

Asthma, gender, and ETS: pathogenic synergy	2005 (Cycle XIV)	$99,500
University of California, Davi	Laurel Gershwin D.V.M., Ph.D.	14IT-0081

Asymmetric Synthesis of (-)-Podophyllotoxin	1993 (Cycle II)	$121,946
University of California, Sant	Joseph Konopelski Ph.D.	2RT-0004

Autocrine Interactions Between Bombesin and its Receptor	1994 (Cycle III)	$316,238
University of California, San<	Daniel Donoghue Ph.D.	3RT-0242

BAG-1, a unique gene involved in smoking-associated cancers	1998 (Cycle VII)	$75,060
The Burnham Institute of Medic	Zhihua Xie Ph.D.	7FT-0092

Bayview-Hunters Point partnership toward smoking cessation	2002 (Cycle XI)	$75,000
University of California, San<	Ruth Malone Ph.D., RN.	11BT-1701

Bayview-Hunters Point partnership toward smoking cessation	2002 (Cycle XI)	$75,000
University of California, San<	Carol McGruder B.A.	11BT-1701

Behavioral effects of neonatal nicotine exposure	2000 (Cycle IX)	$624,780
San Diego State University Res	Edward Riley Ph.D.	9RT-0012

Behavioral epidemiology of tobacco use among gay men	1998 (Cycle VII)	$628,233
University of California, San<	Greg Greenwood PhD	7RT-0013

Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro	1995 (Cycle IV)	$321,199
University of California, San<	Hyam Leffert M.D.	4RT-0076

Benzo[A]pyrene: Biogenetic Effects on Hepatocytes in Vitro	1992 (Cycle I)	$482,971
University of California, San<	Hyam Leffert M.D.	1RT-0137

Bioactive lipids in tobacco related lung cancers	1997 (Cycle VI)	$74,496
University of California, San<	Jerold Chun M.D., Ph.D.	6IT-0375

Biochemical and Functional Characterization of HIP-116	1994 (Cycle III)	$75,600
Salk Institute for Biological<	Philip Sheridan Ph.D.	3FT-0339

Birth defects, smoking and host susceptibility	2003 (Cycle XII)	$466,200
March of Dimes Birth Defects F	Suzan Carmichael PhD	12RT-0098

Bispecific molecular therapy of small cell lung cancer	2001 (Cycle X)	$434,805
University of California, San<	Edward Ball M.D.	10RT-0064

Black-White Differences in Menthol Cigarette Smoking	1992 (Cycle I)	$332,764
University of California, Los<	Murray Jarvik M.D., Ph.D.	1RT-0087

Boosting the immune response against lung cancer	1998 (Cycle VII)	$70,000
University of California, Los<	Marina Stolina Ph.D.	7FT-0035

Brachial Vasoreactivity in Young Adult Smokers	1997 (Cycle VI)	$329,593
Osteoporosis Medical Center	Jacques Barth M.D., Ph.D.	6RT-0053

Brain adaptations to chronic nicotine expsoure	1997 (Cycle VI)	$402,111
University of California, Irvi	Frances Leslie Ph.D.	6RT-0416

Brain imaging in nicotine addiction	2002 (Cycle XI)	$419,881
University of California, Los<	Desmond Smith Ph.D.	11RT-0172

Brain metabolic changes with cigarette craving	1998 (Cycle VII)	$250,850
Brentwood Biomedical Research<	Arthur Brody M.D.	7KT-0098

Brain nAChR Occupancy: Effect of Secondhand Smoke	2007 (Cycle XVI)	$623,841
Brentwood Biomedical Research<	Arthur Brody M.D.	16RT-0098

Brain wave assessment of tobacco cessation readiness	1997 (Cycle VI)	$115,486
Scripps Research Institute	Aaron Ilan Ph.D.	6KT-0312

Bupropion and nicotine dependence: behavior & neurochemisty	2005 (Cycle XIV)	$37,500
Scripps Research Institute	Neil Paterson B.Sc., MBCh.B.	14FT-0056

Bupropion for hospital-based smoking cessation	2003 (Cycle XII)	$485,200
University of California, San<	Joel Simon M.D., M.P.H.	12RT-0148

Bupropion for smoking cessation	1998 (Cycle VII)	$471,154
University of California, San<	Joel Simon M.D., M.P.H.	7RT-0033

California AB13 compliance and ethnicity in urban bars	2003 (Cycle XII)	$769,266
Pacific Institute for Research	Roland Moore BA, MA, Ph.D.	12RT-0116

California pharm-assists for smoking cessation	1999 (Cycle VIII)	$124,689
SRI International	Karen Hudmon Dr.P.H., R.P.H., M.S.	8BT-2301

California pharm-assists for smoking cessation	1999 (Cycle VIII)	$124,689
SRI International	Marilyn Shreve R.Ph.	8BT-2301

Calorigenic and Atherogenic Effects of Smoking and Nicotine	1995 (Cycle IV)	$357,492
University of California, San<	Marc Hellerstein M.D., Ph.D.	4RT-0233

Cambodian research initiative	2003 (Cycle XII)	$106,456
California State University, L	Robert Friis Ph.D.	12BT-2201

Cambodian research initiative	2003 (Cycle XII)	$106,456
California State University, L	Him Chhim MS, MPA	12BT-2201

Can Computer Games Prevent Tobacco Use?	1994 (Cycle III)	$105,362
Stanford University	C. Barr Taylor M.D.	3IT-0114

Carbon monoxide and the brain growth spurt	1998 (Cycle VII)	$464,268
University of California, Los<	John Edmond Ph.D.	7RT-0039

Carbon monoxide as a modulator of myocardial function	1999 (Cycle VIII)	$225,000
University of California, Davi	Ulrike Kreutzer Ph.D.	8KT-0042

Cardiac Arrythmias Before and After Smoking Cessation	1995 (Cycle IV)	$93,780
University of California, San<	Melvin Scheinman M.D.	4RT-0069

Cardiac ion channels and tobacco-related disease	2002 (Cycle XI)	$389,983
University of California, Sant	Carol Vandenberg Ph.D.	11RT-0114

Cardiovascular responses through spinal nicotinic receptors	2001 (Cycle X)	$448,941
University of California, San<	Palmer Taylor Ph.D.	10RT-0107

Cardiovascular responses to nicotine	1997 (Cycle VI)	$430,843
University of California, San<	Palmer Taylor Ph.D.	6RT-0009

Carotid Body Amplification of Exertional Dyspnea in Smokers	1992 (Cycle I)	$196,560
University of California, Los<	Susan Ward Ph.D.	1RT-0272

Case studies of indoor air regulations: role of research	1997 (Cycle VI)	$292,210
University of California, San<	Lisa Bero Ph.D.	6RT-0025

Case study on tobacco use legislation	1992 (Cycle I)	$160,907
RAND Corporation	Peter Jacobson J.D., M.P.H.	1RT-0529

Cell adhesion at nicotinic synapses	2005 (Cycle XIV)	$59,500
University of California, San<	Gallen Triana-Balzer B.A.	14DT-0092

Cell Adhesion Receptors in Atherogenesis	1994 (Cycle III)	$170,341
The Burnham Institute of Medic	Jeffrey Smith Ph.D.	3RT-0258A

Cell Adhesion Receptors in Atherogenesis	1994 (Cycle III)	$391,252
Scripps Research Institute	Jeffrey Smith Ph.D.	3RT-0258